Pfizer's Center for Therapeutic Innovation (CTI) 2015
Request for Translational Proposals: Biotherapeutic and Small Molecule Targets
All researchers, clinicians, and post-docs whose work meets the criteria are invited to apply.For more information about submitting a proposal, please contact Venkat Reddy, Venkateshwar.Reddy@pfizer.com or Nate Hafer, Nathaniel.Hafer@umassmed.edu
Proposal Deadline: Friday, June 12, 2015 - Please submit your proposal to one of the contacts listed above.
CTI is an innovative Pfizer program that partners with leading academic medical centers and patient foundations nationwide to speed the translation of novel targets into potential therapeutics. CTI seeks to identify and partner novel targets with the goal of identifying new compounds and accelerate drug development from validated target to proof-of-mechanism in humans. A partnership with CTI may include collaborative use of Pfizer’s proprietary antibody drug delivery technologies and/or compound library, broad publishing rights and financial awards in the form of milestone and royalty payments for successful programs.
Complete details and instructions can be downloaded here.
The CTI Pre-Proposal template can be downloaded here.